greeksoup/ stock research

AMN Healthcare Services (AMN) FY2023 results: revenue $3.8 billion, down 27.7% on the year

AMN Healthcare Services Inc. (AMN) reported revenue of $3.8 billion for fiscal 2023, the year ended 31 December 2023, down 27.7% on the year before. Net income was $211 million, down 52.6%, and diluted earnings per share $5.36. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2024.

Revenue
$3.8 billion
-27.7% on the year
FY2016FY2023
Operating margin
8.9%
12.3% a year earlier
FY2016FY2023
Net income
$211 million
-52.6% on the year
FY2016FY2023
Diluted EPS
$5.36
-45.9% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue3,7895,2433,984-27.7%
Cost of revenue2,5403,5272,675-28.0%
Gross profit1,2501,7171,310-27.2%
Gross margin33.0%32.7%32.9%
Selling, general and administrative748937730-20.1%
Operating income338647478-47.7%
Operating margin8.9%12.3%12.0%
Interest expense54.140.434.1+34.0%
Pre-tax income284607444-53.1%
Income tax73.6163117-54.7%
Effective tax rate25.9%26.8%26.3%
Net income211444327-52.6%
Net margin5.6%8.5%8.2%
Diluted EPS$5.36$9.90$6.81-45.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow372654305-43.1%
Capital expenditure10475.853.6+36.7%
Free cash flow268578252-53.5%
Free cash flow margin7.1%11.0%6.3%
Cash from investing-412-171-107
Cash from financing10.7-592-34.9
Depreciation and amortisation161137104+17.4%
Share-based compensation18.030.125.2-40.1%
Buybacks4255772.7-26.4%
Diluted shares, weighted39m45m48m-12.3%
Shares outstanding at period end38m42m47m-9.7%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity8311,0441,162-20.3%
Debt1,305844842+54.7%
Operating lease liabilities37.69.413.4+301.7%
Other liabilities7519921,114-24.3%
Total liabilities and equity2,9242,8883,132+1.2%
Fixed assets191149127+28.2%
Goodwill1,112935892+18.8%
Intangible assets474477514-0.6%
Cash and equivalents32.964.5181-49.0%
Receivables623676789-7.7%
Other assets491587628-16.3%
Total assets2,9242,8883,132+1.2%

10-K for the year ended 31 December 2023, filed 22 February 2024: the filing.